SEATTLE GENETICS, INC. DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • May 10th, 2004 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Illinois
This Development and Supply Agreement (the “Agreement”) is entered into this 23rd day of February, 2004 (“Effective Date”) by and between Abbott Laboratories, an Illinois corporation having a principal place of business at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 (“Abbott”), and Seattle Genetics, Inc. having a principal place of business at 21823 – 30th Drive Southeast in Bothell, Washington 98021 (“Seattle Genetics”).
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [*]. PATENT RIGHTS MASTER AGREEMENT AND RESEARCH LICENSE AGREEMENTPatent Rights Master Agreement and Research License Agreement • May 10th, 2004 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • California
This PATENT RIGHTS MASTER AGREEMENT AND RESEARCH LICENSE AGREEMENT (the “Agreement”) is entered into as of January 9, 2004 (the “Effective Date”) by and between PROTEIN DESIGN LABS, INC., a Delaware corporation having its principal office at 34801 Campus Drive, Fremont, California 94555 (“PDL”), and Seattle Genetics, Inc., a Delaware corporation having its principal office at 21823 30th Drive Southeast, Bothell, Washington 98021 (“Seattle Genetics”).
AMENDMENT TO COLLABORATION AGREEMENT BY AND BETWEEN SEATTLE GENETICS, INC. AND PROTEIN DESIGN LABS, INC.Collaboration Agreement • May 10th, 2004 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
This Amendment (“Amendment”) effective as of January 9, 2004 modifies and amends the Collaboration Agreement dated as of June 4, 2001 (the “Collaboration Agreement”) by and between Seattle Genetics, Inc., a Delaware corporation (“SGI”), and Protein Design Labs, Inc., a Delaware corporation (“PDL”), as successor in interest to Eos Biotechnology, Inc. (“Eos”).
PATENT LICENSE AGREEMENT between PROTEIN DESIGN LABS, INC. and SEATTLE GENETICS, INC.Patent License Agreement • May 10th, 2004 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • California
This Agreement (“Agreement”), effective as of January 9, 2004 (“Effective Date”), is made by and between PROTEIN DESIGN LABS, INC., a Delaware corporation having offices at 34801 Campus Drive, Fremont, California 94555 U.S. (hereinafter “PDL”) and SEATTLE GENETICS, INC., a Delaware corporation having its principal office at 21823 30th Drive Southeast, Bothell, Washington 98021 (hereinafter “Seattle Genetics”).
